1. King RJB. Cancer Biology, 2nd edn. Prentice Hall, Edinburgh. 2000.
2. Chen C, Wang G. Mechanisms of hepatocellular carcinoma and challenges and opportunities for molecular targeted therapy. World J Hepatol. 2015;7(15):1964-70. [
DOI:10.4254/wjh.v7.i15.1964] [
PMID] [
]
3. Cui N, Hu M, Khalil RA. Biochemical and Biological Attributes of Matrix Metalloproteinases. Prog Mol Biol Transl Sci. 2017;147:1-73. [
DOI:10.1016/bs.pmbts.2017.02.005] [
PMID] [
]
4. Hua H, Li M, Luo T, Yin Y, Jiang Y. Matrix metalloproteinases in tumorigenesis: an evolving paradigm. Cell Mol Life Sci. 2011;68(23):3853-68. [
DOI:10.1007/s00018-011-0763-x] [
PMID] [
]
5. Johansson N, Ahonen M, Kähäri VM. Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci. 2000;57(1):5-15. [
DOI:10.1007/s000180050495] [
PMID] [
]
6. Pei D. Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP. J Biol Chem. 1999 Mar 26;274(13):8925-32. [
DOI:10.1074/jbc.274.13.8925] [
PMID]
7. Itoh Y, Kajita M, Kinoh H, Mori H, Okada A, Seiki M. Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase. J Biol Chem. 1999;274(48):34260-6. [
DOI:10.1074/jbc.274.48.34260] [
PMID]
8. Yip C, Foidart P, Noël A, Sounni NE. MT4-MMP: The GPI-Anchored Membrane-Type Matrix Metalloprotease with Multiple Functions in Diseases. Int J Mol Sci. 2019;20(2):354. [
DOI:10.3390/ijms20020354] [
PMID] [
]
9. Llano E, Pendás AM, Freije JP, Nakano A, Knäuper V, Murphy G, López-Otin C. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors. Cancer Res. 1999;59(11):2570-6.
10. Santos NP, Colaço AA, Oliveira PA. Animal models as a tool in hepatocellular carcinoma research: A Review. Tumour Biol. 2017;39(3):1010428317695923. [
DOI:10.1177/1010428317695923] [
PMID]
11. Leenders MW, Nijkamp MW, Borel Rinkes IH. Mouse models in liver cancer research: a review of current literature. World J Gastroenterol. 2008;14(45):6915-23. [
DOI:10.3748/wjg.14.6915] [
PMID] [
]
12. Wogan GN. Impacts of chemicals on liver cancer risk. Semin Cancer Biol. 2000;10(3):201-10. [
DOI:10.1006/scbi.2000.0320] [
PMID]
13. Williams GM. Chemicals with carcinogenic activity in the rodent liver; mechanistic evaluation of human risk. Cancer Lett. 1997;117(2):175-88. [
DOI:10.1016/S0304-3835(97)00229-2] [
PMID]
14. Lee SJ, Yum YN, Kim SC, Kim Y, Lim J, Lee WJ, et al. Distinguishing between genotoxic and non-genotoxic hepatocarcinogens by gene expression profiling and bioinformatic pathway analysis. Sci Rep. 2013;3:2783. [
DOI:10.1038/srep02783] [
PMID] [
]
15. Zhang HE, Henderson JM, Gorrell MD. Animal models for hepatocellular carcinoma. Biochim Biophys Acta Mol Basis Dis. 2019;1865(5):993-1002. [
DOI:10.1016/j.bbadis.2018.08.009] [
PMID]
16. Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer. 2005;41(13):1955-68. [
DOI:10.1016/j.ejca.2005.05.009] [
PMID]
17. Campbell FC, Collett GP. Chemopreventive properties of curcumin. Future Oncol. 2005;1(3):405-14. [
DOI:10.1517/14796694.1.3.405] [
PMID]
18. Cao F, Liu T, Xu Y, Xu D, Feng S. Curcumin inhibits cell proliferation and promotes apoptosis in human osteoclastoma cell through MMP-9, NF-κB and JNK signaling pathways. Int J Clin Exp Pathol. 2015;8(6):6037-45.
19. Okimoto RA, Breitenbuecher F, Olivas VR, Wu W, Gini B, Hofree M, et al. Inactivation of Capicua drives cancer metastasis. Nat Genet. 2017;49(1):87-96. [
DOI:10.1038/ng.3728] [
PMID] [
]
20. Chabottaux V, Sounni NE, Pennington CJ, English WR, van den Brûle F, Blacher S, et al. Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases. Cancer Res. 2006 66(10):5165-72. [
DOI:10.1158/0008-5472.CAN-05-3012] [
PMID]
21. English WR, Puente XS, Freije JM, Knauper V, Amour A, Merryweather A, et al. Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2. J Biol Chem. 2000;275(19):14046-55. [
DOI:10.1074/jbc.275.19.14046] [
PMID]
22. Ricci S, D'Esposito V, Oriente F, Formisano P, Di Carlo A. Substrate-zymography: a still worthwhile method for gelatinases analysis in biological samples. Clin Chem Lab Med. 2016;54(8):1281-90.
23. Nguyen-Lefebvre AT, Ajith A, Portik-Dobos V, Horuzsko DD, Arbab AS, Dzutsev A, et al. The innate immune receptor TREM-1 promotes liver injury and fibrosis. J Clin Invest. 2018;128(11):4870-4883. [
DOI:10.1172/JCI98156] [
PMID] [
]
24. Abdelhamid AM, Selim A, Zaafan MA. The Hepatoprotective Effect of Piperine Against Thioacetamide-Induced Liver Fibrosis in Mice: The Involvement of miR-17 and TGF-β/Smads Pathways. Front Mol Biosci. 2021;8:754098. [
DOI:10.3389/fmolb.2021.754098] [
PMID] [
]
25. Wallace MC, Hamesch K, Lunova M, Kim Y, Weiskirchen R, Strnad P, Friedman SL. Standard operating procedures in experimental liver research: thioacetamide model in mice and rats. Lab Anim. 2015;49(1 Suppl):21-9. [
DOI:10.1177/0023677215573040] [
PMID]
26. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979;76(9):4350-4. [
DOI:10.1073/pnas.76.9.4350] [
PMID] [
]
27. Lee TY, Chang HH, Wen CK, Huang TH, Chang YS. Modulation of thioacetamide-induced hepatic inflammations, angiogenesis and fibrosis by andrographolide in mice. J Ethnopharmacol. 2014;158 Pt A:423-30. [
DOI:10.1016/j.jep.2014.10.056] [
PMID]
28. Meis J, Khanna A. RNA amplification and cDNA synthesis for qRT-PCR directly from a single cell. Nat Methods. 2009; 6, i-ii. [
DOI:10.1038/nmeth.f.261]
29. Yu J, He Z, He X, Luo Z, Lian L, Wu B, et al. Comprehensive Analysis of the Expression and Prognosis for MMPs in Human Colorectal Cancer. Front Oncol. 2021;11:771099. [
DOI:10.3389/fonc.2021.771099] [
PMID] [
]
30. Shishodia S. Molecular mechanisms of curcumin action: gene expression. Biofactors. 2013;39(1):37-55. [
DOI:10.1002/biof.1041] [
PMID]
31. Mahmoudi A, Butler AE, Majeed M, Banach M, Sahebkar A. Investigation of the Effect of Curcumin on Protein Targets in NAFLD Using Bioinformatic Analysis. Nutrients. 2022;14(7):1331. [
DOI:10.3390/nu14071331] [
PMID] [
]
32. Cao F, Liu T, Xu Y, Xu D, Feng S. Curcumin inhibits cell proliferation and promotes apoptosis in human osteoclastoma cell through MMP-9, NF-κB and JNK signaling pathways. Int J Clin Exp Pathol. 2015;8(6):6037-45.
33. Choi H, Chun YS, Shin YJ, Ye SK, Kim MS, Park JW. Curcumin attenuates cytochrome P450 induction in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin by ROS-dependently degrading AhR and ARNT. Cancer Sci. 2008;99(12):2518-24. [
DOI:10.1111/j.1349-7006.2008.00984.x] [
PMID] [
]
34. Piper JT, Singhal SS, Salameh MS, Torman RT, Awasthi YC, Awasthi S. Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver. Int J Biochem Cell Biol. 1998;30(4):445-56. [
DOI:10.1016/S1357-2725(98)00015-6] [
PMID]
35. Mudduluru G, George-William JN, Muppala S, Asangani IA, Kumarswamy R, Nelson LD, Allgayer H. Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Biosci Rep. 2011;31(3):185-97. [
DOI:10.1042/BSR20100065] [
PMID]
36. Killian PH, Kronski E, Michalik KM, Barbieri O, Astigiano S, Sommerhoff CP, et al. Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2. Carcinogenesis. 2012;33(12):2507-19. [
DOI:10.1093/carcin/bgs312] [
PMID]
37. Zhang L, Cheng X, Gao Y, Zhang C, Bao J, Guan H, et al. Curcumin inhibits metastasis in human papillary thyroid carcinoma BCPAP cells via down-regulation of the TGF-β/Smad2/3 signaling pathway. Exp Cell Res. 2016;341(2):157-65. [
DOI:10.1016/j.yexcr.2016.01.006] [
PMID]
38. Wang ME, Chen YC, Chen IS, Hsieh SC, Chen SS, Chiu CH. Curcumin protects against thioacetamide-induced hepatic fibrosis by attenuating the inflammatory response and inducing apoptosis of damaged hepatocytes. J Nutr Biochem. 2012;23(10):1352-66. [
DOI:10.1016/j.jnutbio.2011.08.004] [
PMID]
39. García-Niño WR, Pedraza-Chaverrí J. Protective effect of curcumin against heavy metals-induced liver damage. Food Chem Toxicol. 2014;69:182-201. [
DOI:10.1016/j.fct.2014.04.016] [
PMID]
40. Chabottaux V, Sounni NE, Pennington CJ, English WR, van den Brûle F, Blacher S, et al. Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases. Cancer Res. 2006;66(10):5165-72. [
DOI:10.1158/0008-5472.CAN-05-3012] [
PMID]
41. Nuttall RK, Pennington CJ, Taplin J, Wheal A, Yong VW, Forsyth PA, Edwards DR. Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells. Mol Cancer Res. 2003;1(5):333-45.
42. Wang Y, Yu S, Li Y, Luo H. Expression and clinical significance of matrix metalloproteinase-17 and -25 in gastric cancer. Oncol Lett. 2015;9: 671-676. [
DOI:10.3892/ol.2014.2747] [
PMID] [
]
43. Sounni NE, Paye A, Host L, Noël A. MT-MMPS as Regulators of Vessel Stability Associated with Angiogenesis. Front Pharmacol. 2011;2:111. [
DOI:10.3389/fphar.2011.00111] [
PMID] [
]
44. Okimoto RA, Breitenbuecher F, Olivas VR, Wu W, Gini B, Hofree M, et al. Inactivation of Capicua drives cancer metastasis. Nat Genet. 2017;49(1):87-96. [
DOI:10.1038/ng.3728] [
PMID] [
]
45. Benson CS, Babu SD, Radhakrishna S, Selvamurugan N, Ravi Sankar B. Expression of matrix metalloproteinases in human breast cancer tissues. Dis Markers. 2013;34(6):395-405. [
DOI:10.1155/2013/420914] [
PMID] [
]